From a Neurology Today online article:
After an ischemic stroke or transient ischemic attack with evidence of atherosclerosis, patients who had a target LDL cholesterol level of less than 70 mg/dL had a lower risk of subsequent cardiovascular events than those who had a target range of 90 mg to 110 mg/dL.
The American Heart Association/American Stroke Association (AHA/ASA) currently recommends using statins to lower lipid levels in patients after a transient ischemic attack (TIA) or ischemic stroke of atherosclerotic origin, but offers limited guidance on just how intensive this therapy should be.
Now new findings from the Treat Stroke to Target (TST) trial conducted in France and South Korea offer that guidance. The study, led by Pierre Amarenco, MD, chairman of the department of neurology and Stroke Center at Bichat Hospital in Paris, and colleagues, point to a significant improvement in subsequent cardiovascular events when these patients were treated with statins until they reached target low-density lipoprotein (LDL) cholesterol levels of 70 mg/dL or lower.
To read more: https://journals.lww.com/neurotodayonline/Fulltext/2019/12190/Lower_LDL_Targets_After_Ischemic_Stroke.1.aspx/?cid=eTOC%20Issues.2019-neurotodayonline-00132985-201912190-00000&rid=&TargetID=&EjpToken=kUBI82y8eD4bC5NQiWgnbQlwWtm-SH0gXjxdmMaycL1mcSvxVt–tkCrNjLLBDUj-N7wY4–&mkt_tok=eyJpIjoiWmpFMU5ETTBaR1EwWm1FeSIsInQiOiJ0aUNySDdiMmF2aXdYdmhraDRFdXdcLzVLb0NWaW5qNXRNbHM0WVY5ZXhIUWlQdkJjcjVtNUxpSzFQTGk2VXUrZWh0cExaWVhKRlhLekFocnVnN0xyc3JqXC90dlBZZ084ZUNWV2lQVHBmSTJJWTlBXC9CdG5vdVlmQ0xUUzhlc1k4XC9EaGVidmVWUFduV1wvZ1dNWG1iYkppQT09In0%3D